Beijing Tiantan Biological Products Corp Ltd (600161) — Cash Flow Quality Index
Beijing Tiantan Biological Products Corp Ltd (600161) has a Cash Flow Quality Index of 1.71x as of September 2025. Operating cash flow of CN¥318.80 Million exceeds net income of CN¥186.12 Million, indicating high earnings quality where cash backs reported profits. Explore cash efficiency ratio of Beijing Tiantan Biological Products Corp to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Beijing Tiantan Biological Products Corp Ltd Cash Flow Quality Index (1998–2024)
Historical Cash Flow Quality Index for Beijing Tiantan Biological Products Corp Ltd across 27 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Beijing Tiantan Biological Products Corp (600161) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Beijing Tiantan Biological Products Corp Ltd (1998–2024)
Year-by-year earnings quality comparison for Beijing Tiantan Biological Products Corp Ltd. For live market cap and the full company financial profile, see 600161 market cap overview.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.39x | CN¥819.78 Million | CN¥2.11 Billion | ▼ -75.5% |
| 2023 | 1.59x | CN¥2.39 Billion | CN¥1.51 Billion | ▲ +69.7% |
| 2022 | 0.93x | CN¥1.13 Billion | CN¥1.20 Billion | ▲ +1.9% |
| 2021 | 0.92x | CN¥980.35 Million | CN¥1.07 Billion | ▲ +23.2% |
| 2020 | 0.74x | CN¥702.11 Million | CN¥943.08 Million | ▲ +3.6% |
| 2019 | 0.72x | CN¥642.47 Million | CN¥894.25 Million | ▼ -22.0% |
| 2018 | 0.92x | CN¥677.92 Million | CN¥735.90 Million | ▲ +425.6% |
| 2017 | 0.18x | CN¥218.39 Million | CN¥1.25 Billion | ▼ -87.6% |
| 2016 | 1.41x | CN¥428.37 Million | CN¥303.01 Million | ▼ -65.5% |
| 2015 | 4.09x | CN¥473.26 Million | CN¥115.58 Million | ▲ +93.7% |
| 2014 | 2.11x | CN¥477.95 Million | CN¥226.16 Million | ▲ +72.2% |
| 2013 | 1.23x | CN¥566.43 Million | CN¥461.48 Million | ▲ +5.1% |
| 2012 | 1.17x | CN¥432.00 Million | CN¥369.96 Million | ▼ -3.5% |
| 2011 | 1.21x | CN¥353.15 Million | CN¥291.84 Million | ▲ +46.2% |
| 2010 | 0.83x | CN¥184.85 Million | CN¥223.35 Million | ▼ -48.3% |
| 2009 | 1.60x | CN¥448.23 Million | CN¥280.18 Million | ▲ +13.0% |
| 2008 | 1.42x | CN¥276.39 Million | CN¥195.28 Million | ▲ +37.6% |
| 2007 | 1.03x | CN¥153.55 Million | CN¥149.32 Million | ▼ -30.2% |
| 2006 | 1.47x | CN¥154.36 Million | CN¥104.83 Million | ▼ -22.8% |
| 2005 | 1.91x | CN¥131.69 Million | CN¥69.00 Million | ▼ -17.6% |
| 2004 | 2.32x | CN¥110.11 Million | CN¥47.53 Million | ▲ +59.1% |
| 2003 | 1.46x | CN¥62.93 Million | CN¥43.23 Million | ▼ -37.4% |
| 2002 | 2.32x | CN¥84.38 Million | CN¥36.30 Million | ▲ +71.7% |
| 2001 | 1.35x | CN¥46.49 Million | CN¥34.35 Million | ▲ +7.3% |
| 2000 | 1.26x | CN¥47.90 Million | CN¥37.97 Million | ▲ +28.0% |
| 1999 | 0.99x | CN¥42.58 Million | CN¥43.20 Million | ▲ +39.6% |
| 1998 | 0.71x | CN¥23.71 Million | CN¥33.58 Million | — |